| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14,965 |
13,887 |
$1.89M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
9,595 |
8,846 |
$1.81M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,070 |
3,866 |
$296K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,490 |
2,262 |
$249K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
697 |
618 |
$181K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
1,265 |
316 |
$60K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,237 |
1,128 |
$58K |
| 90791 |
Psychiatric diagnostic evaluation |
539 |
509 |
$57K |
| 36415 |
Collection of venous blood by venipuncture |
17,783 |
15,873 |
$56K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,248 |
1,456 |
$55K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,528 |
1,162 |
$51K |
| 71046 |
Radiologic examination, chest; 2 views |
1,149 |
987 |
$50K |
| 86900 |
|
682 |
579 |
$48K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,584 |
1,353 |
$43K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
454 |
447 |
$42K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,585 |
1,353 |
$42K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
139 |
132 |
$35K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,113 |
939 |
$31K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
769 |
497 |
$20K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
161 |
155 |
$17K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
361 |
328 |
$12K |
| H0015 |
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education |
150 |
29 |
$12K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
609 |
517 |
$10K |
| 90837 |
Psychotherapy, 53 minutes with patient |
173 |
85 |
$10K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
158 |
149 |
$8K |
| 71045 |
Radiologic examination, chest; single view |
164 |
146 |
$7K |
| 86803 |
|
702 |
597 |
$7K |
| 86780 |
|
645 |
546 |
$7K |
| 86762 |
|
619 |
527 |
$6K |
| 70450 |
Computed tomography, head or brain; without contrast material |
50 |
49 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
973 |
840 |
$5K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
17,355 |
15,791 |
$5K |
| 87340 |
|
615 |
522 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
223 |
181 |
$4K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,506 |
3,147 |
$4K |
| 87210 |
|
1,369 |
1,179 |
$3K |
| Q3014 |
Telehealth originating site facility fee |
162 |
131 |
$3K |
| 82950 |
|
357 |
327 |
$3K |
| 90834 |
Psychotherapy, 45 minutes with patient |
43 |
17 |
$2K |
| 90686 |
|
169 |
142 |
$2K |
| 86850 |
|
795 |
679 |
$2K |
| 90832 |
Psychotherapy, 30 minutes with patient |
30 |
24 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
50 |
47 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
65 |
45 |
$1K |
| 88142 |
|
74 |
63 |
$1K |
| 87081 |
|
250 |
219 |
$1K |
| 80053 |
Comprehensive metabolic panel |
13,563 |
12,418 |
$1K |
| 59430 |
|
14 |
14 |
$819.24 |
| 81025 |
|
227 |
201 |
$737.65 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
128 |
37 |
$719.24 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
102 |
80 |
$546.77 |
| 81000 |
|
7,256 |
6,702 |
$457.57 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
121 |
117 |
$344.72 |
| 88141 |
|
26 |
26 |
$305.62 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
125 |
118 |
$161.70 |
| 85018 |
|
69 |
67 |
$139.57 |
| 85014 |
|
69 |
67 |
$139.35 |
| 86787 |
|
16 |
12 |
$135.99 |
| 83605 |
|
2,761 |
2,475 |
$118.66 |
| 84484 |
|
722 |
567 |
$64.45 |
| 86140 |
|
2,604 |
2,368 |
$47.73 |
| 86901 |
|
684 |
581 |
$24.05 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
84 |
79 |
$15.70 |
| 83690 |
|
461 |
432 |
$12.91 |
| 87581 |
|
28 |
25 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
164 |
150 |
$0.00 |
| 83880 |
|
43 |
37 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
63 |
60 |
$0.00 |
| 85652 |
|
26 |
24 |
$0.00 |
| 81001 |
|
123 |
107 |
$0.00 |
| 83735 |
|
46 |
42 |
$0.00 |
| 87486 |
|
28 |
25 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
41 |
38 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
25 |
15 |
$0.00 |
| 87040 |
|
22 |
13 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
15 |
14 |
$0.00 |
| 85379 |
|
13 |
12 |
$0.00 |
| 84145 |
|
233 |
214 |
$0.00 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
186 |
174 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
907 |
787 |
$0.00 |
| 85610 |
|
52 |
49 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
33 |
29 |
$0.00 |
| 87631 |
|
25 |
23 |
$0.00 |
| 90715 |
|
32 |
28 |
$0.00 |
| 0100U |
|
13 |
12 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
28 |
25 |
$0.00 |
| 81003 |
|
12 |
12 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
14 |
12 |
$0.00 |